Arcutis Biotherapeutics, Inc. (ARQT) Q1 2025 Earnings Call Transcript

  • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Amanda Sheldon - Head of Corporate Communications Frank Watanabe - President and CEO Todd Edwards - CCO Patrick Burnett - Chief Medical Officer Latha Vairavan - CFO Conference Call Participants Vikram Purohit - Morgan Stanley Seamus Fernandez - Guggenheim Securities Uy Ear - Mizuho Tyler Van Buren - TD Cowen Kambiz Yazdi - Jefferies Serge Belanger - Needham Douglas Tsao - H.C. Wainwright Operator Good day and welcome to Arcutis Biotherapeutics' 2025 First Quarter Financial Results Conference Call.